BL-M08D1 for recurrent or metastatic gynecological and other cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 18 but not older than 75.
- You have recurrent (came back after treatment) or metastatic (spread) gynecological cancer or another solid tumor.
- You can take care of yourself (ECOG 0 or 1) and are expected to live at least 3 more months.
- You have at least one tumor that can be measured on a scan, and you can provide a tumor sample (old or new).
- You have recovered from side effects of previous treatments (to mild or none), and your heart, kidney, and liver function are good.
- You are not pregnant or breastfeeding, and if you can have children, you agree to use birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This study tests a new drug called BL-M09D1 for people with certain gynecologic cancers or other solid tumors that have not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
This study tests a new drug called BL-M08D1 for people with nasopharyngeal cancer or other solid tumors that have returned or spread. The trial is in early phases to see how safe the drug is and whether it can shrink tumors.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This trial tests an investigational drug called BL-M09D1 for people with advanced bladder cancer (urothelial carcinoma) or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and help people live longer.
Hear when a new Gynecological Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.